Difference between revisions of "Disease Category Overview Template"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
[unchecked revision][unchecked revision]
 
(4 intermediate revisions by the same user not shown)
Line 1: Line 1:
 
{{Under Construction}}
 
{{Under Construction}}
 +
 
==Primary Author(s)*==
 
==Primary Author(s)*==
  
 
Put your text here
 
Put your text here
 +
 +
__TOC__
 +
 +
==Graphical Data Links==
 +
 +
Put your graphics here
  
 
==General Disease Overview / Description of Cancer Category==
 
==General Disease Overview / Description of Cancer Category==
Line 10: Line 17:
 
==WHO Classification Pages (Includes Links to Content)==
 
==WHO Classification Pages (Includes Links to Content)==
  
Put your text here, EXAMPLE #[[Chromophobe renal cell carcinoma]]
+
Put your text here (use "Link" icon at top of page)
  
 
==Other Related Pages (Includes Links to Content)==
 
==Other Related Pages (Includes Links to Content)==
  
Put your text here, EXAMPLE #[[Acute Myeloid Leukemia (AML) with Mutated FLT3]]
+
Put your text here (use "Link" icon at top of page)
  
 
==Additional Information==
 
==Additional Information==
Line 21: Line 28:
  
 
==References==
 
==References==
 
+
(use "Cite" icon at top of page)
 +
<references />
 
=== EXAMPLE Book ===
 
=== EXAMPLE Book ===
#Arber DA, et al., (2008). Acute myeloid leukaemia with recurrent genetic abnormalities, in World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edition. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, Editors. IARC Press: Lyon, France, p117-118.
+
#Arber DA, et al., (2017). Acute myeloid leukaemia with recurrent genetic abnormalities, in World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised 4th edition. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, and Siebert R, Editors. IARC Press: Lyon, France, p129-171.
 
 
=== EXAMPLE Journal Article ===
 
#Li Y, et al., (2001). Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nat Genet 28:220-221, PMID 11431691.
 
  
 
== Notes ==
 
== Notes ==
 
<nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page.  If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage).  Additional global feedback or concerns are also welcome.
 
<nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page.  If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage).  Additional global feedback or concerns are also welcome.

Latest revision as of 12:38, 10 January 2021

Primary Author(s)*

Put your text here

Graphical Data Links

Put your graphics here

General Disease Overview / Description of Cancer Category

Put your text here

WHO Classification Pages (Includes Links to Content)

Put your text here (use "Link" icon at top of page)

Other Related Pages (Includes Links to Content)

Put your text here (use "Link" icon at top of page)

Additional Information

Put your text here

References

(use "Cite" icon at top of page)

EXAMPLE Book

  1. Arber DA, et al., (2017). Acute myeloid leukaemia with recurrent genetic abnormalities, in World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised 4th edition. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, and Siebert R, Editors. IARC Press: Lyon, France, p129-171.

Notes

*Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage). Additional global feedback or concerns are also welcome.